
Dhanwantri Bioremedies Private Limited
Nursery plantation and supply of herbal plants for medicinal use.
Nursery plantation and supply of herbal plants for medicinal use.
Dhanwantri Bioremedies Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 July 2011 and has a history of 13 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Victory Herbals Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nagendra Deoke and Nitin Devke serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U01120MH2011PTC219488
219488
Private Limited Indian Non-Government Company
06 Jul 2011
30 Sep 2022
31 Mar 2022
Unlisted
Roc Mumbai
Dhanwantri Bioremedies Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Honey & Sweeteners, Dietary Supplements, Flaxseed Oil Capsule, Herbal Powder, Stevia Powder, Diabetes Medicine, Ayurvedic Powder and Medicinal Herbs, Stevia Sweetener, Nutraceuticals & Dietary Supplements.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nagendra Deoke ![]() | Director | 02-May-2017 | Current |
Nitin Devke ![]() | Additional Director | 03-Apr-2023 | Current |
Dhanwantri Bioremedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 18.09% increase. The company also saw a substantial fall in profitability, with a 139.74% decrease in profit. The company's net worth Soared by an impressive increase of 897.59%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2020, Dhanwantri Bioremedies had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Nagendra Deoke is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dhanwantri Bioremedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dhanwantri Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantri Bioremedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nitin Dasharath Devke was appointed as a Additional Director was appointed as a Additional Director on 03 Apr 2023 & has been associated with this company since 1 year 11 months .
Dhanwantri Bioremedies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Dhanwantri Bioremedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai.
Nagendra Rupaji Deoke was appointed as a Director was appointed as a Director on 02 May 2017 & has been associated with this company since 7 years 10 months .
Dhanwantri Bioremedies Private Limited was registered on 06 Jul 2011 with Roc Mumbai & aged 13 years 8 months as per MCA records.
Dhanwantri Bioremedies Private Limited was incorporated on 06 Jul 2011.
The authorized share capital of Dhanwantri Bioremedies Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.82 Cr.
Currently 2 directors are associated with Dhanwantri Bioremedies Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Dhanwantri Bioremedies Private Limited is 312 The Jewel Roxy Building Near Panchratna Opera House, India, Mumbai, Maharashtra, 400004.
The corporate identification number (CIN) of Dhanwantri Bioremedies Private Limited is U01120MH2011PTC219488 and the company number is 219488 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Dhanwantri Bioremedies Private Limited has risen by 18.09%.
The financial reports for the fiscal year 2020 indicates that The net worth of Dhanwantri Bioremedies Private Limited has experienced an upsurge of 897.59%.
The most recent Balance Sheet for Dhanwantri Bioremedies Private Limited was filed with the ROC on 31 Mar 2022.
PB
RS
NM
JS
ND
PA